84
74
Growth Score
-1 pts
Heat Score
18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
526434
Neoantigen is a high-tech and innovative enterprise specializing in the research and development of individualized tumor vaccines.
About the Company
Neoantigen is a high-tech and innovative enterprise specializing in the research and development of individualized tumor vaccines. It is committed to developing various individualized immunotherapy products based on neoantigens. The founder of the company proposed the concept of neoantigen-based therapy in China in 2005 and is one of the leaders in
the research and development of neoantigen-related products in the world.
